Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Articles
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (52)
  • 2025 (77)
  • 2024 (93)
  • 2023 (65)
  • 2022 (110)
  • 2021 (106)
  • 2020 (80)
  • 2019 (98)
  • 2018 (86)
  • 2017 (50)
  • 2016 (29)
  • 2015 (76)
  • 2014 (104)
  • 2013 (123)
  • 2012 (59)
  • 2011 (76)

Subject

  • Drug Trafficking (326)
  • Arrests/Convictions - Major (108)
  • Guilty Plea (85)
  • Synthetic drugs (77)
  • Guns/Weapons (63)
  • OCDETF/Task Force (61)
  • Prescription Drugs (42)
  • Take Back Day (39)
  • Outreach/Drug Prevention (30)
  • Fake Pills (28)
  • Money Laundering (26)
  • Pharmaceuticals/Pharmacists/Physicians (25)
  • Diversion Division (20)
  • Major Law Enforcement Operation (18)
  • Public and Media Affairs - also see Congressional Affairs (18)
  • Overdose (17)
  • Seizures (Drugs/Property) (17)
  • Fentanyl Awareness (16)
  • Congressional Affairs (12)
  • One Pill Can Kill (12)
  • Press Conferences (11)
  • Red Ribbon (9)
  • Extraditions (8)
  • Fentanyl Free America (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • HIDTA (6)
  • Task Forces/Task Force Officers (6)
  • Intergovernmental Affairs (5)
  • International/Foreign Operations (5)
  • Asset Forfeiture (4)
  • Narcoterrorism (4)
  • Counterfeit Pills (3)
  • Critical Incident (3)
  • Dark Web- Internet Trafficking (3)
  • Gangs (3)
  • Other (3)
  • Campaigns (2)
  • Intelligence Division - Intelligence Products (2)
  • Scam Calls (2)
  • Terrorism (2)
  • Cartel (1)
  • Museum and Visitors Center (1)

Drug Name

  • Fentanyl (178)
  • Cocaine (171)
  • Methamphetamine (156)
  • Heroin (61)
  • Marijuana (Cannabis) (28)
  • Oxycodone (24)
  • Opioids (14)
  • Synthetic Opioids (11)
  • Ecstasy/MDMA (6)
  • Hydromorphone (6)
  • Amphetamines (4)
  • Benzodiazepines (2)
  • Marijuana Concentrates (2)
  • Methadone (2)
  • GHB (1)
  • Ketamine (1)
  • Morphine (1)
  • Psilocybin (1)
  • Steroids (1)

Field Division

  • Atlanta (792)
  • Caribbean (83)
  • Caribbean (1)
  • Chicago (638)
  • Dallas (325)
  • Detroit (364)
  • El Paso (357)
  • Headquarters (422)
  • Houston (919)
  • Los Angeles (311)
  • Louisville (90)
  • Miami (867)
  • New England (2431)
  • New Jersey (495)
  • New Orleans (501)
  • New York (1538)
  • Omaha (150)
  • Philadelphia (140)
  • Phoenix (278)
  • Rocky Mountain (168)
  • San Diego (249)
  • San Francisco (856)
  • Seattle (833)
  • St. Louis (817)
  • Washington, DC (619)
Clear All Results
1284 Results - Showing 841 to 850
PRESS RELEASE

DEA Meets With Pharmaceutical Industry Leaders Today To Discuss Collaboratively Preventing Prescription Drug Misuse And Abuse

WASHINGTON - U.S. Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg and the Chief of DEA’s Office of Diversion Control, Lou Milione hosted a meeting today in Washington with industry leaders representing the prescription drug supply chain in America. The purpose of their dialogue was to discuss ways to minimize pharmaceutical...
PRESS RELEASE

Palm Beach County Resident Convicted Of Narcotics Trafficking And Unlawful Gun Possession

MIAMI - Following a four-day trial, a federal jury in West Palm Beach, Florida, convicted Kevin Raphael Bully of narcotics trafficking and unlawful possession of a firearm. Adolphus P. Wright, Special Agent in Charge, Drug Enforcement (DEA), Miami Division and Wifredo A. Ferrer, United States Attorney for the Southern District...
PRESS RELEASE

DEA Administrator Chuck Rosenberg Statement On Walgreens’ Prescription Drug Take Back Initiative

WASHINGTON - The United States Drug Enforcement (DEA) commends Walgreens for their commitment to install secure collection bins for unused prescription drugs in over 500 of their stores in 40 states. "Take back programs are an important and easy way for the public to anonymously dispose of their unwanted, unused...
PRESS RELEASE

FBI, DEA Release Documentary Film Addressing Heroin/Prescription Drug Abuse

WASHINGTON - In an effort to combat the growing epidemic of prescription drug and heroin abuse, leaders of the FBI and DEA today unveiled a documentary aimed at educating students and young adults about the dangers of the addiction. “Chasing the Dragon” is a 45-minute documentary film that profiles the...
PRESS RELEASE

DEA And European Authorities Uncover Massive Hizballah Drug And Money Laundering Scheme

WASHINGTON - The United States Drug Enforcement (DEA) today announced significant enforcement activity including arrests targeting Lebanese Hizballah’s External Security Organization Business Affairs (BAC), which is involved in international criminal activities such as drug trafficking and drug proceed money laundering. These proceeds are used to purchase weapons for Hizballah for...
PRESS RELEASE

DEA Statement On The Capture Of Joaquin “Chapo” Guzman-Loera

WASHINGTON - The capture of Joaquin “Chapo” Guzman-Loera is a victory for the rule of law and the Mexican people and government. The arrest is a significant achievement in our shared fight against transnational organized crime, violence, and drug trafficking. It is further evidence of our two countries’ resolve to...
PRESS RELEASE

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

WASHINGTON - The United States Drug Enforcement (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances (CSA) for those who are conducting FDA-approved clinical trials on (CBD), an extract of the marijuana plant. These modifications will streamline the research process regarding CBD’s possible medicinal value and...
PRESS RELEASE

DEA Announces “360 Strategy” To Address Heroin, Prescription Drugs And Violent Crime

PITTSBURGH - The United States Drug Enforcement Administration today announced Pittsburgh as the pilot city for a comprehensive law enforcement and prevention “360 Strategy” to help cities dealing with a heroin and prescription drug abuse epidemic, and its associated violent crime. DEA Special Agent in Charge for the Philadelphia Division...
PRESS RELEASE

DEA Releases 2015 Drug Threat Assessment: Heroin And Painkiller Abuse Continue To Concern

WASHINGTON - DEA Acting Administrator Chuck Rosenberg today announced results from the 2015 National Drug Threat (NDTA), which found that drug overdose deaths are the leading cause of injury death in the United States, ahead of deaths from motor vehicle accidents and firearms. In 2013, more than 46,000 people in...
PRESS RELEASE

151 Arrested In DEA-Led Investigation Of Synthetic Drug Rings

WASHINGTON - The Drug Enforcement (DEA), Immigration and Customs (ICE) Homeland Security (HSI), Customs and Border (CBP), along with other federal, state, and local law enforcement today concluded a 15-month, nationwide drug interdiction effort that resulted in 151 arrests in 16 states. The enforcement action, known as Project Synergy III...

Pagination

  • First page «
  • Previous
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • Current page 85
  • Page 86
  • Page 87
  • Page 88
  • Page 89
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster